Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human coagulation factor IX in hemophilia B with bleeding
CTR20171073Phase 3Completed
- Sponsor
- Sichuan Yuanda Shuyang Pharmaceutical
- Start
- Sep 2017
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor ix in hemophilia B (HB), sponsored by Sichuan Yuanda Shuyang Pharmaceutical. Started Sep 2017; status: completed.
02
Drugs
coagulation factor ix
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20171073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171073.